Sonire Therapeutics

Sonics brings new future to cancer patients

Headquarters: Tokyo, California
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: sonire-therapeutics.com
Total Funding: $18.0M
Last Round: $18.0M Series AApr 2026
Rounds: 1

About

Sonire Therapeutics is developing a next-generation high-intensity focused ultrasound (HIFU) treatment system for unresectable pancreatic cancer. The company uses acoustic engineering to target tumors non-invasively and has received breakthrough device designation in Japan. It is conducting a randomized Phase 2 study of its HIFU therapy system.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Series ASeries AApr 2026

Apr 2026

Sonire Therapeutics

About

Tech & App Stack

Sign up to view funding chart

Funding History

Investors

Sign up to view investors

Similar Companies